Holder evidence
50
SEC ownership of Legend Biotech Corp
Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0001801198.
Lead holder
FMR LLC
13D/G signal
FMR LLC
Latest evidence
31 Mar 2026
- CIK
- 0001801198
- Symbol
- LEGN on Nasdaq
- Location
- Somerset, NJ
- SEC evidence mix
- 13D/G, 13F, and 3/4/5
- Lead holder
- FMR LLC
- Latest large-stake holder
- FMR LLC
- Latest evidence date
- 31 Mar 2026
Issuer identity
Ownership snapshot
Ownership snapshot
Top shareholders of Legend Biotech Corp (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Lead holder
FMR LLC
13D/G signal
FMR LLC
Evidence rows
50
Latest as of
31 Mar 2026
13D/G
13F
3/4/5
Lead comparable stake: 13%
13D/G row: FMR LLC
Showing 1-8 of 50 holder rows.
Rank 1 holder
FMR LLC
13D/G
13F
- Ownership
- 13%
- Position
- $1.05B
Rank 2 holder
PRICE T ROWE ASSOCIATES INC /MD/
13D/G
- Ownership
- 3.7%
- Position
- $233.38M
Rank 3 holder
Ying Huang
3/4/5
- Ownership
- 0.07%
- Position
- $2.17M
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| FMR LLC |
13D/G
13F
Company
|
13%
|
$1,049,921,245
48,294,445 shares
|
-$147,815,434 | 31 Dec 2025 |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13D/G
T. Rowe Price Associates, Inc.
|
3.7%
|
$233,379,028
6,808,023 shares
|
$0 | 31 Dec 2024 |
| Ying Huang |
3/4/5
Chief Executive Officer, Director
|
0.07%
|
$2,170,031
247,438 shares
|
-$87,139 | 25 Mar 2026 |
| Darren Xiaohui Ji |
3/4/5
Director
|
0.02%
|
$1,259,516
63,773 shares
|
— | 18 Mar 2026 |
| Corazon (corsee) D. Sanders |
3/4/5
Director
|
0.02%
|
$1,167,521
59,115 shares
|
— | 18 Mar 2026 |
| Patrick John Casey |
3/4/5
Director
|
0.01%
|
$1,078,429
54,604 shares
|
— | 18 Mar 2026 |
| Li Mao |
3/4/5
Director
|
0.01%
|
$875,517
44,330 shares
|
— | 18 Mar 2026 |
| Tomas J. Heyman |
3/4/5
Director
|
0.01%
|
$646,496
32,734 shares
|
— | 18 Mar 2026 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Forms 3/4/5 flow
Insider trading overview
Net insider flow leans to selling over the last 12 months. Net value: -$87,139.
Buys
$0
Insiders: 0
Sells
$87,139
Insiders: 1
Net
-$87,139
Shares: -9,936
Window
Last 12 months
4 rolling buckets
Buy value
Sell value
Shares: 0
Shares: 9,936
| Window (months) | Buy shares | Sell shares | Buy value | Sell value | Net value |
|---|---|---|---|---|---|
| 0-3 | 0 | 9,936 | $0 | $87,139 | -$87,139 |
| 3-6 | 0 | 0 | $0 | $0 | $0 |
| 6-9 | 0 | 0 | $0 | $0 | $0 |
| 9-12 | 0 | 0 | $0 | $0 | $0 |
Reporting owners
Insider holders from Forms 3/4/5
Showing 1-12 of 12 reporting-owner rows connected to Legend Biotech Corp. Open a relationship link for the CIK-to-CIK filing trail.
Rows
12
Lead holder
Ying Huang
Net 12M change
-$87,139
Latest report
25 Mar 2026
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| Ying Huang | Chief Executive Officer, Director | $2,170,031 | -$87,139 | -3.9% | Filing P/S | 25 Mar 2026 |
| Darren Xiaohui Ji | Director | $1,259,516 | Mixed | 18 Mar 2026 | ||
| Corazon (corsee) D. Sanders | Director | $1,167,521 | Mixed | 18 Mar 2026 | ||
| Patrick John Casey | Director | $1,078,429 | Mixed | 18 Mar 2026 | ||
| Li Mao | Director | $875,517 | Mixed | 18 Mar 2026 | ||
| Tomas J. Heyman | Director | $646,496 | Mixed | 18 Mar 2026 | ||
| Gareth Kung | Director | $621,848 | Mixed | 18 Mar 2026 | ||
| Peter Salovey | Director | $528,628 | Mixed | 18 Mar 2026 | ||
| Ye Wang | Director | $316 | Mixed | 18 Mar 2026 | ||
| Fangliang Zhang | Director | Mixed | 18 Mar 2026 | |||
| Carlos E. Santos | Chief Financial Officer | Mixed | 18 Mar 2026 | |||
| Robin Meng | Director | Mixed | 18 Mar 2026 |
Recent insider transactions for Legend Biotech Corp
Showing up to 300 most recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | Reported value | Reported price | Shares | Shares owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| Ying Huang | LEGN | Ordinary Shares | Sale | -3.86% | $87,139 | $8.77 | -9,936 | 247,438 | 25 Mar 2026 | Direct |
* indicates a reported price that failed the local validity check.